This board has become a kvetching post of pointing
Post# of 148288
Like I said about SAVA, for perspective, it has become 2.2 billion market cap for alzheimer's in just a few trading days with scant data and zero sales or revenue.
Using that benchmark, and the fact that LL data success in alzheimer's is a long way down the road, CYDY is pre-qualified for it, and many more, as real potential drivers.
I guess I have to say something about the evil shorts keeping us down before this post will stand without getting deleted. maybe